Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-08

Clinical Trial Update: Effect of Arabinoxylan Oligosaccharides Consumption on Insulin Resistance in Patients With Metabolic Syndrome [NA]

View source ↗

Summary

A clinical trial evaluating the effect of arabinoxylan oligosaccharides on insulin resistance in metabolic syndrome has completed; no results are provided in th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arabinoxylan-Oligosaccharides (arabinoxylan-oligosaccharides)

Snippet

Sponsor: KU Leuven | Conditions: Metabolic Syndrome | NA | Status: COMPLETED